RECALL: Pharmaceutical company recalls around 490,000 epinephrine injectors

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

Screen Shot 2015-10-28 at 8.06.22 PMPharmaceutical company Sanofi has recalled its Auvi-Q epinephrine auto-injectors, saying they potentially could deliver the wrong-sized dose.

The company’s U.S. division said in a news release there have been 26 cases of suspected malfunctions. There have been no deaths.

Patients have described symptoms of “underlying hypersensitivity reaction,” Sanofi said.

“We’re doing this voluntary recall as a precaution,” said Dr. Paul Chew, global chief medical officer for Sanofi, “and we have temporarily stopped manufacturing.”

Chew advised people who have one of the recalled epinephrine pens to call their doctors and get a prescription for a new and different auto-injector.

Customers can call 1-866-726-6340 to get information on how to return their pens and get a refund or costs from a new pen purchase.

The website is

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.